Results 31 to 40 of about 11,993 (190)
Abstract Children with developmental and epileptic encephalopathies (DEEs) face cognitive and behavioral challenges that may have a greater impact than seizures on their quality of life (QoL). The need to assess these nonseizure outcomes for evaluating treatments is increasingly recognized.
Cinzia Correale +9 more
wiley +1 more source
Abstract Objective Infantile epileptic spasms syndrome (IESS) is an epileptic encephalopathy requiring rapid diagnosis and treatment to optimize neurodevelopmental outcomes. Although multiple national and regional guidelines exist, recommendations vary.
Gozde Erdemir +21 more
wiley +1 more source
Resumen: Introducción: Existen pocos estudios que demuestren el perfil demografico y social de la epilepsia en poblaciones vulnerables y de bajos recursos económicos.
C.A. Espinosa Jovel +5 more
doaj +1 more source
Resumen: Introducción: Los reportes de los resultados quirúrgicos en los pacientes con epilepsia fármaco-resistente del lóbulo temporal sin anormalidades histológicas son escasos.
J.C. Benedetti-Isaac +6 more
doaj +1 more source
Abstract Objective Developmental and epileptic encephalopathies (DEEs) are characterized by drug‐resistant seizures and developmental slowing/regression. We examined the efficacy and tolerability of fenfluramine (FFA) in pediatric and adult patients with Lennox–Gastaut syndrome (LGS), Dravet syndrome (DS), and other DEEs.
Vicente Villanueva +29 more
wiley +1 more source
Background The Basic Health Unit (Unidade Básica de Saúde – UBS, in Portuguese) is the first point of contact in the public healthcare system for people with epilepsy. Primary care professionals need to appropriately diagnose, treat, and refer,
Vanessa Cristina Colares Lessa +4 more
doaj +1 more source
Resumen: Introducción: La epilepsia es uno de los trastornos neurológicos más frecuentes de la infancia, presentándose en un 0,5-1%. Aproximadamente un 20-30% de los pacientes son farmacorresistentes.
A. Ulate-Campos +10 more
doaj +1 more source
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer +7 more
wiley +1 more source

